ESC 365 - Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis

ESC Professional Premium Access

Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis

Session: Treatment of acute coronary syndromes in clinical practice

Topic: Pharmacotherapy

Speaker: Doctor S. Al Said (Boston, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Samer Al Said

Harvard Medical School, Boston (United States of America)

0 follower

7 more presentations in this session

Effect of evolocumab on platelet function in patients with acute coronary syndromes. An analysis of the randomized, double-blind, placebo-controlled EVOPACS Trial

Speaker: Doctor K. Koskinas (Bern, CH)

ARCANGELO: an observational, prospective study with acute coronary syndrome patients undergoing percutaneous coronary intervention who receive cangrelor transitioning to oral P2Y12 inhibitors

Speaker: Doctor L. De Luca (Pavia, IT)

SGLT2 inhibitor for secondary prevention in acute myocardial infarction patients with diabetes mellitus

Speaker: Professor D. Kim (Seoul, KR)

The effect of sodium-glucose co-transporter-2 inhibitors following anterior ST-segment elevation myocardial infarction

Speaker: Doctor G. Incesu (Istanbul, TR)

Comparison of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in myocardial infarction patients with type 2 diabetes

Speaker: Doctor J. Tjerkaski (Stockholm, SE)

Access the full session

Treatment of acute coronary syndromes in clinical practice

Speakers: Doctor S. Al Said, Doctor K. Koskinas, Doctor L. De Luca, Professor D. Kim, Doctor G. Incesu...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources